Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 1 for:    cdx-353-002
Previous Study | Return to List | Next Study

Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Clinipace LTD
Kansas City Bioanalytical Laboratories
Beckloff Associates, Inc.
Information provided by (Responsible Party):
Spectrum Pharmaceuticals, Inc
ClinicalTrials.gov Identifier:
NCT01660633
First received: August 2, 2012
Last updated: July 17, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2014
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)